Lympro Marketing example for the Alzheimer's RUO market:

'Improve Clinical Trial Success with Lympro':
Almost all Alzheimer's clinical trials fail due to incorrect diagnosis and carry significant cost. Lympro is a simple blood test that can identify even early stage Alzheimer's at 30% less cost - priceless for Pharma companies development programs and for families waiting for a treatment.

Lympro is Effective:
'Improves clinical trial success' with at least 90% accuracy.

Lympro is Stage Independent:
'Enhances patient targeting in clinical trials' with equal efficacy proven in early, mid, and late stage Alzheimer's.

Lympro is Convenient:
'Improved speed of clinical trials' using a simple blood test with 1 biomarker.

Lympro is Cost Effective:
'Reduces clinical trial cost' by at least 30% compared to currently available diagnostics.

Very compelling story about to be in the market...